Tumor-associated immune cells hinder frontline chemotherapy drug in pancreatic cancer
Wednesday, March 27, 2019 - 08:20
in Health & Medicine
A frontline chemotherapy drug given to patients with pancreatic cancer is made less effective because similar compounds released by tumor-associated immune cells block the drug's action.